Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104628720A offers high purity moxifloxacin hydrochloride refining. Enhances supply chain reliability and cost reduction in pharmaceutical manufacturing.
Patent CN110563623A reveals a novel L-(+)-selenomethionine synthesis using selenium powder. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing.
Novel synthesis patent CN118666668A offers high purity above 99% and scalable purification for pharmaceutical intermediates supply chain stability and cost efficiency in global manufacturing.
Novel recovery method for L-camphorsulfonic acid resolving agent ensuring high purity and yield over 89 percent for cost-effective Clopidogrel manufacturing.
Advanced synthesis of DL-neopentyl glycine via glycylglycine acetylation. High-purity amino acid intermediate for pharma. Cost-effective scalable production.
Novel reduction and resolution process for high-purity Pitavastatin Calcium. Enhances supply chain reliability and reduces manufacturing costs for global pharma partners.
Discover the novel chemical resolution method for c-Met inhibitor PF-2341066. This patent analysis highlights cost reduction and scalable manufacturing for pharmaceutical intermediates.
Novel biocatalytic route for l-menthol using Bacillus subtilis ECU0554. High substrate tolerance up to 500mM and >96% ee. Ideal for flavor and pharma intermediates.
Patent CN100404686C details enzymatic resolution of C-24 hydroxy vitamin D isomers, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN103435523B reveals a cost-effective route for Sitafloxacin intermediates ensuring supply chain stability and high purity for global pharmaceutical manufacturing partners.
Novel patent CN106188047B details high-yield synthesis of moxifloxacin intermediate. Offers cost reduction and supply chain reliability for pharmaceutical manufacturers seeking scalable solutions.
Novel enzymatic method for L-2-aminobutyric acid production. Low cost, high yield, scalable process for pharmaceutical intermediates and supply chain optimization.
Advanced enzymatic resolution synthesis for chiral antifungal intermediates. Cost-effective, scalable production of high-purity pharmaceutical ingredients with superior stereocontrol.
Patent CN106397391A reveals efficient DKR synthesis for chiral alcohols offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Optimized sertraline hydrochloride synthesis via patent CN103524354A offers enhanced purity and scalable manufacturing for global pharmaceutical supply chains and cost efficiency.
Patent CN104418784B details a novel resolution method for antiviral intermediates. Achieve high de% purity and scalable manufacturing for pharmaceutical supply chains.
Patent CN114685558A reveals a high-yield preparation method for Remdesivir intermediate Compound I, offering significant cost reduction and supply chain reliability for global API manufacturers.
Patent CN105712889B reveals a cost-effective route for Ticagrelor intermediates. Discover kinetic resolution benefits and supply chain advantages for pharmaceutical manufacturing.
Patent CN112279765B details a novel NHC-catalyzed kinetic resolution for chiral alpha-fluoroketones, offering mild conditions and high efficiency for pharmaceutical intermediate manufacturing.
Patent CN102757367A details a cost-effective splitting process for DL-benzene ethyl sulfonic acid using L-HPG, offering high purity and supply chain stability for pharmaceutical intermediates.